Found 21 matching trials
Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases EARLY_PHASE1 RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, w...
Show More Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. PHASE3 This 2 arm study will compare the efficacy and safety of Avastin plus Herce...
Show More Location
Multiple Locations
Learn More & Join Trial
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" PHASE2 The purpose of this study is to evaluate a novel neoadjuvant regimen for in...
Show More Location
Hospital Auxilio Mutuo Cancer Center
Treatments Being Tested
Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab Learn More & Join Trial
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer PHASE2 This phase II trial studies how well trastuzumab and pertuzumab or bevacizu...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer PHASE1 Multi-center, non randomised, open label, non controlled pilot study. Evalu...
Show More Location
Institut Salah Azaiz
Learn More & Join Trial
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer PHASE2 The main purpose is to learn if adding bevacizumab to standard chemotherapy...
Show More Location
Clearview Cancer Institute- Huntsville
Learn More & Join Trial
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors PHASE1 This study will evaluate the safety and tolerability of R1507 in combinatio...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer PHASE2 This single arm, open-label study will evaluate the safety and efficacy of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Neoadjuvant Chemotherapy of Breast Cancer PHASE2 The purpose of this study is to evaluate the pathological CR rate in breast...
Show More Location
Auxilio Mutuo Cancer Center
Learn More & Join Trial
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab PHASE3 The trial will determine the value of adding bevacizumab to chemotherapy pl...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial